(Q37282163)

19 August 2017

1 reference

title

Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood (English)

1 reference

attention deficit hyperactivity disorder

19 August 2017

0 references

1 reference

1 reference

Russell A Barkley

1

1 reference

PubMed ID

18824825

19 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

19 August 2017

Postgraduate Medicine

1 reference

19 August 2017

120

1 reference

19 August 2017

3

1 reference

19 August 2017

48-59

1 reference

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

19 August 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Attention deficit/hyperactivity disorder across the lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

The effect of ADHD on the life of an individual, their family, and community from preschool to adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Quality of life of adolescent males with attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Psychosocial interventions in attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Adolescent outcome of boys with attention-deficit/hyperactivity disorder and social disability: results from a 4-year longitudinal follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Hyperactive boys almost grown up. I. Psychiatric status

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Prospective follow-up of girls with attention-deficit/hyperactivity disorder into adolescence: Evidence for continuing cross-domain impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Families of children with attention-deficit/hyperactivity disorder: review and recommendations for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

The psychosocial functioning of children and spouses of adults with ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

The marital and family functioning of adults with ADHD and their spouses

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Adolescents with attention deficit and hyperactivity disorder/learning disability and their proneness to accidents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Inattentive and hyperactive behaviors and driving offenses in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Driving anger and other driving-related behaviors in high and low ADHD symptom college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Driving anger and driving behavior in adults with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Adult psychiatric status of hyperactive boys grown up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Do stimulants improve self-esteem in children with ADHD and peer problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Correlates of comorbid psychopathology in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Ethnic and regional differences in primary care visits for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

A systematic review of the associations between dose regimens and medication compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Effect of methylphenidate formulation for attention deficit hyperactivity disorder on patterns and outcomes of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Stimulant treatment over five years: adherence, effectiveness, and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Attention-deficit/hyperactivity disorder: increased costs for patients and their families

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

A review of the economic burden of ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Economic implications of attention-deficit hyperactivity disorder for healthcare systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Long-term relationships between symptoms of Attention Deficit Hyperactivity Disorder and self-esteem in a prospective longitudinal study of twins

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

Attentional Difficulties in Middle Childhood and Psychosocial Outcomes in Young Adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1907

21 January 2018

Identifiers

DOI

10.3810/PGM.2008.09.1907

1 reference

19 August 2017

1 reference

PubMed ID

18824825